nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydromorphone—Blood amylase increased—Telbivudine—hepatitis B	0.0419	0.0471	CcSEcCtD
Hydromorphone—Hyperpathia—Lamivudine—hepatitis B	0.0411	0.0462	CcSEcCtD
Hydromorphone—Respiratory disorder—Lamivudine—hepatitis B	0.0334	0.0375	CcSEcCtD
Hydromorphone—Respiration abnormal—Lamivudine—hepatitis B	0.0314	0.0353	CcSEcCtD
Hydromorphone—Amylase increased—Telbivudine—hepatitis B	0.0192	0.0216	CcSEcCtD
Hydromorphone—Hepatomegaly—Entecavir—hepatitis B	0.0157	0.0177	CcSEcCtD
Hydromorphone—Naloxone—TLR4—hepatitis B	0.0152	0.889	CrCbGaD
Hydromorphone—Hepatomegaly—Telbivudine—hepatitis B	0.0129	0.0145	CcSEcCtD
Hydromorphone—Urinary hesitation—Lamivudine—hepatitis B	0.0126	0.0141	CcSEcCtD
Hydromorphone—Rhinorrhoea—Telbivudine—hepatitis B	0.0113	0.0127	CcSEcCtD
Hydromorphone—Amylase increased—Lamivudine—hepatitis B	0.0108	0.0122	CcSEcCtD
Hydromorphone—Chest discomfort—Telbivudine—hepatitis B	0.0103	0.0116	CcSEcCtD
Hydromorphone—Suicide—Lamivudine—hepatitis B	0.00995	0.0112	CcSEcCtD
Hydromorphone—UGT1A9—Nicotine Metabolism—CYP2A6—hepatitis B	0.00896	0.0961	CbGpPWpGaD
Hydromorphone—Completed suicide—Lamivudine—hepatitis B	0.00877	0.00986	CcSEcCtD
Hydromorphone—Anaphylactoid reaction—Entecavir—hepatitis B	0.00836	0.0094	CcSEcCtD
Hydromorphone—Abdominal pain upper—Entecavir—hepatitis B	0.00739	0.00831	CcSEcCtD
Hydromorphone—Hepatomegaly—Lamivudine—hepatitis B	0.00729	0.00819	CcSEcCtD
Hydromorphone—Pain in extremity—Telbivudine—hepatitis B	0.00665	0.00747	CcSEcCtD
Hydromorphone—Hyperaesthesia—Lamivudine—hepatitis B	0.00657	0.00739	CcSEcCtD
Hydromorphone—Migraine—Telbivudine—hepatitis B	0.00654	0.00735	CcSEcCtD
Hydromorphone—Rhinorrhoea—Lamivudine—hepatitis B	0.00637	0.00716	CcSEcCtD
Hydromorphone—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00617	0.00694	CcSEcCtD
Hydromorphone—Abdominal pain upper—Telbivudine—hepatitis B	0.00607	0.00682	CcSEcCtD
Hydromorphone—Cramp muscle—Telbivudine—hepatitis B	0.00598	0.00673	CcSEcCtD
Hydromorphone—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00598	0.00673	CcSEcCtD
Hydromorphone—Nasopharyngitis—Telbivudine—hepatitis B	0.00594	0.00668	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Entecavir—hepatitis B	0.0059	0.00663	CcSEcCtD
Hydromorphone—Gastritis—Telbivudine—hepatitis B	0.00588	0.00661	CcSEcCtD
Hydromorphone—Muscular weakness—Telbivudine—hepatitis B	0.00586	0.00659	CcSEcCtD
Hydromorphone—Abdominal distension—Telbivudine—hepatitis B	0.00578	0.0065	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00575	0.00647	CcSEcCtD
Hydromorphone—Drug interaction—Lamivudine—hepatitis B	0.00556	0.00625	CcSEcCtD
Hydromorphone—Oedema peripheral—Entecavir—hepatitis B	0.00551	0.0062	CcSEcCtD
Hydromorphone—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00539	0.00606	CcSEcCtD
Hydromorphone—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00537	0.00603	CcSEcCtD
Hydromorphone—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00535	0.00602	CcSEcCtD
Hydromorphone—Eructation—Lamivudine—hepatitis B	0.00507	0.0057	CcSEcCtD
Hydromorphone—Immune system disorder—Entecavir—hepatitis B	0.00505	0.00568	CcSEcCtD
Hydromorphone—Wheezing—Lamivudine—hepatitis B	0.00501	0.00563	CcSEcCtD
Hydromorphone—Mental disorder—Entecavir—hepatitis B	0.0049	0.00551	CcSEcCtD
Hydromorphone—Malnutrition—Entecavir—hepatitis B	0.00487	0.00548	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Telbivudine—hepatitis B	0.00484	0.00544	CcSEcCtD
Hydromorphone—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00475	0.00534	CcSEcCtD
Hydromorphone—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00468	0.00526	CcSEcCtD
Hydromorphone—Urine output increased—Lamivudine—hepatitis B	0.00466	0.00524	CcSEcCtD
Hydromorphone—Back pain—Adefovir Dipivoxil—hepatitis B	0.0046	0.00517	CcSEcCtD
Hydromorphone—Hypoaesthesia—Telbivudine—hepatitis B	0.00457	0.00514	CcSEcCtD
Hydromorphone—Connective tissue disorder—Telbivudine—hepatitis B	0.00452	0.00508	CcSEcCtD
Hydromorphone—Leukopenia—Entecavir—hepatitis B	0.00436	0.0049	CcSEcCtD
Hydromorphone—Polyuria—Lamivudine—hepatitis B	0.00427	0.00479	CcSEcCtD
Hydromorphone—Gastroenteritis—Lamivudine—hepatitis B	0.00423	0.00475	CcSEcCtD
Hydromorphone—Cough—Adefovir Dipivoxil—hepatitis B	0.00415	0.00466	CcSEcCtD
Hydromorphone—Mediastinal disorder—Telbivudine—hepatitis B	0.00414	0.00466	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00412	0.00463	CcSEcCtD
Hydromorphone—Injury—Lamivudine—hepatitis B	0.00407	0.00458	CcSEcCtD
Hydromorphone—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00405	0.00455	CcSEcCtD
Hydromorphone—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00405	0.00455	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00402	0.00452	CcSEcCtD
Hydromorphone—Malnutrition—Telbivudine—hepatitis B	0.004	0.0045	CcSEcCtD
Hydromorphone—Anaphylactic shock—Entecavir—hepatitis B	0.00398	0.00447	CcSEcCtD
Hydromorphone—PTGS1—Eicosanoid Synthesis—GGT2—hepatitis B	0.00398	0.0426	CbGpPWpGaD
Hydromorphone—Infection—Entecavir—hepatitis B	0.00395	0.00444	CcSEcCtD
Hydromorphone—Dysgeusia—Telbivudine—hepatitis B	0.00392	0.00441	CcSEcCtD
Hydromorphone—Nervous system disorder—Entecavir—hepatitis B	0.0039	0.00438	CcSEcCtD
Hydromorphone—Back pain—Telbivudine—hepatitis B	0.00387	0.00435	CcSEcCtD
Hydromorphone—Skin disorder—Entecavir—hepatitis B	0.00386	0.00434	CcSEcCtD
Hydromorphone—Muscle spasms—Telbivudine—hepatitis B	0.00385	0.00433	CcSEcCtD
Hydromorphone—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.0038	0.00428	CcSEcCtD
Hydromorphone—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00377	0.00424	CcSEcCtD
Hydromorphone—Ill-defined disorder—Telbivudine—hepatitis B	0.00371	0.00417	CcSEcCtD
Hydromorphone—Anorexia—Adefovir Dipivoxil—hepatitis B	0.0037	0.00416	CcSEcCtD
Hydromorphone—Migraine—Lamivudine—hepatitis B	0.00369	0.00414	CcSEcCtD
Hydromorphone—Affect lability—Lamivudine—hepatitis B	0.00369	0.00414	CcSEcCtD
Hydromorphone—Malaise—Telbivudine—hepatitis B	0.00361	0.00406	CcSEcCtD
Hydromorphone—Insomnia—Entecavir—hepatitis B	0.0036	0.00404	CcSEcCtD
Hydromorphone—Mood swings—Lamivudine—hepatitis B	0.00355	0.00399	CcSEcCtD
Hydromorphone—Somnolence—Entecavir—hepatitis B	0.00353	0.00397	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00353	0.00397	CcSEcCtD
Hydromorphone—Dyspepsia—Entecavir—hepatitis B	0.0035	0.00393	CcSEcCtD
Hydromorphone—Cough—Telbivudine—hepatitis B	0.00349	0.00393	CcSEcCtD
Hydromorphone—Dehydration—Lamivudine—hepatitis B	0.00348	0.00392	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Entecavir—hepatitis B	0.00343	0.00386	CcSEcCtD
Hydromorphone—Fatigue—Entecavir—hepatitis B	0.00343	0.00385	CcSEcCtD
Hydromorphone—Abdominal pain upper—Lamivudine—hepatitis B	0.00342	0.00384	CcSEcCtD
Hydromorphone—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00341	0.00384	CcSEcCtD
Hydromorphone—Arthralgia—Telbivudine—hepatitis B	0.00341	0.00383	CcSEcCtD
Hydromorphone—Chest pain—Telbivudine—hepatitis B	0.00341	0.00383	CcSEcCtD
Hydromorphone—Myalgia—Telbivudine—hepatitis B	0.00341	0.00383	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00338	0.0038	CcSEcCtD
Hydromorphone—Cramp muscle—Lamivudine—hepatitis B	0.00337	0.00379	CcSEcCtD
Hydromorphone—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00337	0.00379	CcSEcCtD
Hydromorphone—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00337	0.00379	CcSEcCtD
Hydromorphone—Discomfort—Telbivudine—hepatitis B	0.00337	0.00378	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00335	0.00376	CcSEcCtD
Hydromorphone—Nasopharyngitis—Lamivudine—hepatitis B	0.00335	0.00376	CcSEcCtD
Hydromorphone—Muscular weakness—Lamivudine—hepatitis B	0.0033	0.00371	CcSEcCtD
Hydromorphone—Abdominal distension—Lamivudine—hepatitis B	0.00326	0.00366	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Entecavir—hepatitis B	0.00325	0.00365	CcSEcCtD
Hydromorphone—Dysphagia—Lamivudine—hepatitis B	0.00324	0.00364	CcSEcCtD
Hydromorphone—Nervous system disorder—Telbivudine—hepatitis B	0.0032	0.0036	CcSEcCtD
Hydromorphone—Skin disorder—Telbivudine—hepatitis B	0.00317	0.00357	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00317	0.00357	CcSEcCtD
Hydromorphone—Sweating increased—Lamivudine—hepatitis B	0.00315	0.00354	CcSEcCtD
Hydromorphone—Body temperature increased—Entecavir—hepatitis B	0.00314	0.00353	CcSEcCtD
Hydromorphone—Abdominal pain—Entecavir—hepatitis B	0.00314	0.00353	CcSEcCtD
Hydromorphone—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00307	0.00345	CcSEcCtD
Hydromorphone—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00307	0.00345	CcSEcCtD
Hydromorphone—Dysuria—Lamivudine—hepatitis B	0.00303	0.0034	CcSEcCtD
Hydromorphone—Pollakiuria—Lamivudine—hepatitis B	0.00299	0.00336	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00298	0.00334	CcSEcCtD
Hydromorphone—Insomnia—Telbivudine—hepatitis B	0.00295	0.00332	CcSEcCtD
Hydromorphone—Paraesthesia—Telbivudine—hepatitis B	0.00293	0.0033	CcSEcCtD
Hydromorphone—Depression—Lamivudine—hepatitis B	0.00288	0.00323	CcSEcCtD
Hydromorphone—Dyspepsia—Telbivudine—hepatitis B	0.00288	0.00323	CcSEcCtD
Hydromorphone—Asthenia—Entecavir—hepatitis B	0.00285	0.00321	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00282	0.00317	CcSEcCtD
Hydromorphone—Fatigue—Telbivudine—hepatitis B	0.00282	0.00317	CcSEcCtD
Hydromorphone—Stomatitis—Lamivudine—hepatitis B	0.00281	0.00316	CcSEcCtD
Hydromorphone—Pain—Telbivudine—hepatitis B	0.00279	0.00314	CcSEcCtD
Hydromorphone—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00278	0.00313	CcSEcCtD
Hydromorphone—Sweating—Lamivudine—hepatitis B	0.00277	0.00311	CcSEcCtD
Hydromorphone—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00274	0.00309	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Lamivudine—hepatitis B	0.00273	0.00307	CcSEcCtD
Hydromorphone—Diarrhoea—Entecavir—hepatitis B	0.00272	0.00306	CcSEcCtD
Hydromorphone—Feeling abnormal—Telbivudine—hepatitis B	0.00269	0.00303	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Telbivudine—hepatitis B	0.00267	0.003	CcSEcCtD
Hydromorphone—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00265	0.00298	CcSEcCtD
Hydromorphone—Dizziness—Entecavir—hepatitis B	0.00263	0.00296	CcSEcCtD
Hydromorphone—Rhinitis—Lamivudine—hepatitis B	0.0026	0.00292	CcSEcCtD
Hydromorphone—Abdominal pain—Telbivudine—hepatitis B	0.00258	0.0029	CcSEcCtD
Hydromorphone—Body temperature increased—Telbivudine—hepatitis B	0.00258	0.0029	CcSEcCtD
Hydromorphone—Hypoaesthesia—Lamivudine—hepatitis B	0.00258	0.0029	CcSEcCtD
Hydromorphone—Connective tissue disorder—Lamivudine—hepatitis B	0.00255	0.00286	CcSEcCtD
Hydromorphone—Vomiting—Entecavir—hepatitis B	0.00253	0.00284	CcSEcCtD
Hydromorphone—Rash—Entecavir—hepatitis B	0.00251	0.00282	CcSEcCtD
Hydromorphone—Dermatitis—Entecavir—hepatitis B	0.0025	0.00282	CcSEcCtD
Hydromorphone—Headache—Entecavir—hepatitis B	0.00249	0.0028	CcSEcCtD
Hydromorphone—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00247	0.00277	CcSEcCtD
Hydromorphone—Rash—Adefovir Dipivoxil—hepatitis B	0.00245	0.00275	CcSEcCtD
Hydromorphone—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00244	0.00275	CcSEcCtD
Hydromorphone—Headache—Adefovir Dipivoxil—hepatitis B	0.00243	0.00273	CcSEcCtD
Hydromorphone—CYP2D6—CYP2E1 reactions—CYP2A6—hepatitis B	0.00238	0.0256	CbGpPWpGaD
Hydromorphone—CYP2C9—CYP2E1 reactions—CYP2A6—hepatitis B	0.00236	0.0253	CbGpPWpGaD
Hydromorphone—Nausea—Entecavir—hepatitis B	0.00236	0.00265	CcSEcCtD
Hydromorphone—UGT1A9—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00235	0.0252	CbGpPWpGaD
Hydromorphone—Asthenia—Telbivudine—hepatitis B	0.00234	0.00263	CcSEcCtD
Hydromorphone—Immune system disorder—Lamivudine—hepatitis B	0.00234	0.00263	CcSEcCtD
Hydromorphone—Mediastinal disorder—Lamivudine—hepatitis B	0.00233	0.00262	CcSEcCtD
Hydromorphone—Chills—Lamivudine—hepatitis B	0.00232	0.00261	CcSEcCtD
Hydromorphone—Pruritus—Telbivudine—hepatitis B	0.00231	0.0026	CcSEcCtD
Hydromorphone—Nausea—Adefovir Dipivoxil—hepatitis B	0.0023	0.00259	CcSEcCtD
Hydromorphone—Malnutrition—Lamivudine—hepatitis B	0.00226	0.00254	CcSEcCtD
Hydromorphone—Erythema—Lamivudine—hepatitis B	0.00226	0.00254	CcSEcCtD
Hydromorphone—Diarrhoea—Telbivudine—hepatitis B	0.00223	0.00251	CcSEcCtD
Hydromorphone—Flatulence—Lamivudine—hepatitis B	0.00222	0.0025	CcSEcCtD
Hydromorphone—Tension—Lamivudine—hepatitis B	0.00221	0.00249	CcSEcCtD
Hydromorphone—Dysgeusia—Lamivudine—hepatitis B	0.00221	0.00248	CcSEcCtD
Hydromorphone—Nervousness—Lamivudine—hepatitis B	0.00219	0.00246	CcSEcCtD
Hydromorphone—Back pain—Lamivudine—hepatitis B	0.00218	0.00245	CcSEcCtD
Hydromorphone—Muscle spasms—Lamivudine—hepatitis B	0.00217	0.00244	CcSEcCtD
Hydromorphone—Dizziness—Telbivudine—hepatitis B	0.00216	0.00243	CcSEcCtD
Hydromorphone—Tremor—Lamivudine—hepatitis B	0.00211	0.00238	CcSEcCtD
Hydromorphone—Ill-defined disorder—Lamivudine—hepatitis B	0.00209	0.00235	CcSEcCtD
Hydromorphone—Vomiting—Telbivudine—hepatitis B	0.00208	0.00233	CcSEcCtD
Hydromorphone—Angioedema—Lamivudine—hepatitis B	0.00206	0.00232	CcSEcCtD
Hydromorphone—Rash—Telbivudine—hepatitis B	0.00206	0.00231	CcSEcCtD
Hydromorphone—Dermatitis—Telbivudine—hepatitis B	0.00206	0.00231	CcSEcCtD
Hydromorphone—Headache—Telbivudine—hepatitis B	0.00205	0.0023	CcSEcCtD
Hydromorphone—Malaise—Lamivudine—hepatitis B	0.00203	0.00229	CcSEcCtD
Hydromorphone—Vertigo—Lamivudine—hepatitis B	0.00203	0.00228	CcSEcCtD
Hydromorphone—Syncope—Lamivudine—hepatitis B	0.00202	0.00227	CcSEcCtD
Hydromorphone—Leukopenia—Lamivudine—hepatitis B	0.00202	0.00227	CcSEcCtD
Hydromorphone—Loss of consciousness—Lamivudine—hepatitis B	0.00198	0.00223	CcSEcCtD
Hydromorphone—Cough—Lamivudine—hepatitis B	0.00197	0.00221	CcSEcCtD
Hydromorphone—Convulsion—Lamivudine—hepatitis B	0.00195	0.0022	CcSEcCtD
Hydromorphone—Nausea—Telbivudine—hepatitis B	0.00194	0.00218	CcSEcCtD
Hydromorphone—Arthralgia—Lamivudine—hepatitis B	0.00192	0.00216	CcSEcCtD
Hydromorphone—Chest pain—Lamivudine—hepatitis B	0.00192	0.00216	CcSEcCtD
Hydromorphone—Myalgia—Lamivudine—hepatitis B	0.00192	0.00216	CcSEcCtD
Hydromorphone—Anxiety—Lamivudine—hepatitis B	0.00191	0.00215	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00191	0.00214	CcSEcCtD
Hydromorphone—Naloxone—ALB—hepatitis B	0.0019	0.111	CrCbGaD
Hydromorphone—Discomfort—Lamivudine—hepatitis B	0.0019	0.00213	CcSEcCtD
Hydromorphone—PTGS1—Eicosanoid Synthesis—GGT1—hepatitis B	0.00188	0.0202	CbGpPWpGaD
Hydromorphone—Dry mouth—Lamivudine—hepatitis B	0.00188	0.00211	CcSEcCtD
Hydromorphone—Confusional state—Lamivudine—hepatitis B	0.00186	0.00209	CcSEcCtD
Hydromorphone—Anaphylactic shock—Lamivudine—hepatitis B	0.00184	0.00207	CcSEcCtD
Hydromorphone—Infection—Lamivudine—hepatitis B	0.00183	0.00206	CcSEcCtD
Hydromorphone—Shock—Lamivudine—hepatitis B	0.00181	0.00204	CcSEcCtD
Hydromorphone—Nervous system disorder—Lamivudine—hepatitis B	0.00181	0.00203	CcSEcCtD
Hydromorphone—Skin disorder—Lamivudine—hepatitis B	0.00179	0.00201	CcSEcCtD
Hydromorphone—Hyperhidrosis—Lamivudine—hepatitis B	0.00178	0.002	CcSEcCtD
Hydromorphone—CYP2D6—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.00177	0.0189	CbGpPWpGaD
Hydromorphone—Anorexia—Lamivudine—hepatitis B	0.00175	0.00197	CcSEcCtD
Hydromorphone—UGT1A9—Phase II conjugation—GGT2—hepatitis B	0.00172	0.0185	CbGpPWpGaD
Hydromorphone—Hypotension—Lamivudine—hepatitis B	0.00172	0.00193	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00168	0.00189	CcSEcCtD
Hydromorphone—Insomnia—Lamivudine—hepatitis B	0.00166	0.00187	CcSEcCtD
Hydromorphone—CYP3A4—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.00166	0.0178	CbGpPWpGaD
Hydromorphone—Paraesthesia—Lamivudine—hepatitis B	0.00165	0.00186	CcSEcCtD
Hydromorphone—Dyspnoea—Lamivudine—hepatitis B	0.00164	0.00184	CcSEcCtD
Hydromorphone—Somnolence—Lamivudine—hepatitis B	0.00164	0.00184	CcSEcCtD
Hydromorphone—Dyspepsia—Lamivudine—hepatitis B	0.00162	0.00182	CcSEcCtD
Hydromorphone—Decreased appetite—Lamivudine—hepatitis B	0.0016	0.0018	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00159	0.00179	CcSEcCtD
Hydromorphone—Fatigue—Lamivudine—hepatitis B	0.00159	0.00178	CcSEcCtD
Hydromorphone—Pain—Lamivudine—hepatitis B	0.00157	0.00177	CcSEcCtD
Hydromorphone—Constipation—Lamivudine—hepatitis B	0.00157	0.00177	CcSEcCtD
Hydromorphone—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—hepatitis B	0.00154	0.0166	CbGpPWpGaD
Hydromorphone—Feeling abnormal—Lamivudine—hepatitis B	0.00152	0.00171	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Lamivudine—hepatitis B	0.00151	0.00169	CcSEcCtD
Hydromorphone—CYP2D6—Xenobiotics—CYP2A6—hepatitis B	0.00148	0.0158	CbGpPWpGaD
Hydromorphone—CYP2C9—Xenobiotics—CYP2A6—hepatitis B	0.00147	0.0157	CbGpPWpGaD
Hydromorphone—Urticaria—Lamivudine—hepatitis B	0.00146	0.00164	CcSEcCtD
Hydromorphone—Body temperature increased—Lamivudine—hepatitis B	0.00146	0.00164	CcSEcCtD
Hydromorphone—Abdominal pain—Lamivudine—hepatitis B	0.00146	0.00164	CcSEcCtD
Hydromorphone—CYP2D6—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00142	0.0152	CbGpPWpGaD
Hydromorphone—CYP2C9—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00141	0.0151	CbGpPWpGaD
Hydromorphone—PTGS1—Selenium Micronutrient Network—GGT2—hepatitis B	0.00141	0.0151	CbGpPWpGaD
Hydromorphone—Hypersensitivity—Lamivudine—hepatitis B	0.00136	0.00152	CcSEcCtD
Hydromorphone—Asthenia—Lamivudine—hepatitis B	0.00132	0.00148	CcSEcCtD
Hydromorphone—Pruritus—Lamivudine—hepatitis B	0.0013	0.00146	CcSEcCtD
Hydromorphone—Diarrhoea—Lamivudine—hepatitis B	0.00126	0.00142	CcSEcCtD
Hydromorphone—Dizziness—Lamivudine—hepatitis B	0.00122	0.00137	CcSEcCtD
Hydromorphone—Vomiting—Lamivudine—hepatitis B	0.00117	0.00132	CcSEcCtD
Hydromorphone—Rash—Lamivudine—hepatitis B	0.00116	0.0013	CcSEcCtD
Hydromorphone—Dermatitis—Lamivudine—hepatitis B	0.00116	0.0013	CcSEcCtD
Hydromorphone—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.00116	0.0124	CbGpPWpGaD
Hydromorphone—Headache—Lamivudine—hepatitis B	0.00115	0.0013	CcSEcCtD
Hydromorphone—UGT1A9—NRF2 pathway—GGT2—hepatitis B	0.00115	0.0123	CbGpPWpGaD
Hydromorphone—Nausea—Lamivudine—hepatitis B	0.00109	0.00123	CcSEcCtD
Hydromorphone—PTGS1—Arachidonic acid metabolism—GGT1—hepatitis B	0.00105	0.0112	CbGpPWpGaD
Hydromorphone—UGT1A9—Metapathway biotransformation—AKR1B1—hepatitis B	0.00104	0.0111	CbGpPWpGaD
Hydromorphone—UGT1A9—Biological oxidations—GGT2—hepatitis B	0.00101	0.0108	CbGpPWpGaD
Hydromorphone—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00101	0.0108	CbGpPWpGaD
Hydromorphone—CYP3A4—Xenobiotics—CYP2A6—hepatitis B	0.000966	0.0104	CbGpPWpGaD
Hydromorphone—PTGS1—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000938	0.0101	CbGpPWpGaD
Hydromorphone—CYP3A4—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000929	0.00996	CbGpPWpGaD
Hydromorphone—OPRD1—Peptide GPCRs—CCR5—hepatitis B	0.000923	0.0099	CbGpPWpGaD
Hydromorphone—OPRM1—IL4-mediated signaling events—IL10—hepatitis B	0.000871	0.00934	CbGpPWpGaD
Hydromorphone—OPRM1—IL4-mediated signaling events—CD40LG—hepatitis B	0.000871	0.00934	CbGpPWpGaD
Hydromorphone—PTGS1—Biological oxidations—GGT2—hepatitis B	0.000823	0.00882	CbGpPWpGaD
Hydromorphone—UGT1A9—Phase II conjugation—GGT1—hepatitis B	0.000816	0.00875	CbGpPWpGaD
Hydromorphone—OPRK1—Peptide GPCRs—CCR5—hepatitis B	0.000809	0.00868	CbGpPWpGaD
Hydromorphone—CYP3A4—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.000786	0.00843	CbGpPWpGaD
Hydromorphone—PTGS1—Overview of nanoparticle effects—TNF—hepatitis B	0.000712	0.00764	CbGpPWpGaD
Hydromorphone—UGT1A9—NRF2 pathway—CYP2A6—hepatitis B	0.000697	0.00747	CbGpPWpGaD
Hydromorphone—OPRM1—Peptide GPCRs—CCR5—hepatitis B	0.000684	0.00734	CbGpPWpGaD
Hydromorphone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—hepatitis B	0.000665	0.00713	CbGpPWpGaD
Hydromorphone—PTGS1—Selenium Micronutrient Network—GGT1—hepatitis B	0.000665	0.00713	CbGpPWpGaD
Hydromorphone—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000663	0.00711	CbGpPWpGaD
Hydromorphone—OPRM1—TCR Signaling Pathway—CD8A—hepatitis B	0.00064	0.00686	CbGpPWpGaD
Hydromorphone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000614	0.00658	CbGpPWpGaD
Hydromorphone—UGT1A9—Biological oxidations—CYP2A6—hepatitis B	0.000611	0.00656	CbGpPWpGaD
Hydromorphone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000608	0.00652	CbGpPWpGaD
Hydromorphone—CYP2D6—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000606	0.00649	CbGpPWpGaD
Hydromorphone—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.0006	0.00644	CbGpPWpGaD
Hydromorphone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—hepatitis B	0.000591	0.00634	CbGpPWpGaD
Hydromorphone—OPRM1—TCR Signaling Pathway—CCR5—hepatitis B	0.000585	0.00627	CbGpPWpGaD
Hydromorphone—OPRM1—TCR Signaling Pathway—FAS—hepatitis B	0.00058	0.00622	CbGpPWpGaD
Hydromorphone—PTGS1—Overview of nanoparticle effects—IL6—hepatitis B	0.000575	0.00616	CbGpPWpGaD
Hydromorphone—OPRD1—Peptide ligand-binding receptors—CXCL10—hepatitis B	0.00056	0.006	CbGpPWpGaD
Hydromorphone—CYP2C9—Arachidonic acid metabolism—GGT1—hepatitis B	0.00055	0.00589	CbGpPWpGaD
Hydromorphone—UGT1A9—NRF2 pathway—GGT1—hepatitis B	0.000544	0.00583	CbGpPWpGaD
Hydromorphone—PTGS1—Biological oxidations—CYP2A6—hepatitis B	0.000498	0.00534	CbGpPWpGaD
Hydromorphone—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000498	0.00533	CbGpPWpGaD
Hydromorphone—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000493	0.00529	CbGpPWpGaD
Hydromorphone—OPRK1—Peptide ligand-binding receptors—CXCL10—hepatitis B	0.000491	0.00526	CbGpPWpGaD
Hydromorphone—UGT1A9—Biological oxidations—GGT1—hepatitis B	0.000477	0.00512	CbGpPWpGaD
Hydromorphone—OPRD1—G alpha (i) signalling events—CXCL10—hepatitis B	0.000472	0.00506	CbGpPWpGaD
Hydromorphone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	0.000461	0.00495	CbGpPWpGaD
Hydromorphone—CYP2D6—Metapathway biotransformation—AKR1B1—hepatitis B	0.000449	0.00481	CbGpPWpGaD
Hydromorphone—CYP2C9—Metapathway biotransformation—AKR1B1—hepatitis B	0.000445	0.00477	CbGpPWpGaD
Hydromorphone—CYP2D6—Biological oxidations—GGT2—hepatitis B	0.000436	0.00468	CbGpPWpGaD
Hydromorphone—OPRD1—Peptide ligand-binding receptors—CCR5—hepatitis B	0.000434	0.00466	CbGpPWpGaD
Hydromorphone—CYP2C9—Biological oxidations—GGT2—hepatitis B	0.000432	0.00464	CbGpPWpGaD
Hydromorphone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	0.000431	0.00462	CbGpPWpGaD
Hydromorphone—PTGS1—Selenium Micronutrient Network—F2—hepatitis B	0.000426	0.00457	CbGpPWpGaD
Hydromorphone—OPRM1—Peptide ligand-binding receptors—CXCL10—hepatitis B	0.000415	0.00445	CbGpPWpGaD
Hydromorphone—OPRK1—G alpha (i) signalling events—CXCL10—hepatitis B	0.000414	0.00444	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000404	0.00433	CbGpPWpGaD
Hydromorphone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000401	0.0043	CbGpPWpGaD
Hydromorphone—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000396	0.00425	CbGpPWpGaD
Hydromorphone—PTGS1—Biological oxidations—GGT1—hepatitis B	0.000389	0.00417	CbGpPWpGaD
Hydromorphone—OPRK1—Peptide ligand-binding receptors—CCR5—hepatitis B	0.000381	0.00408	CbGpPWpGaD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.000375	0.00403	CbGpPWpGaD
Hydromorphone—OPRD1—Peptide ligand-binding receptors—F2—hepatitis B	0.000372	0.00399	CbGpPWpGaD
Hydromorphone—OPRM1—TCR Signaling Pathway—CD4—hepatitis B	0.000367	0.00394	CbGpPWpGaD
Hydromorphone—OPRD1—G alpha (i) signalling events—CCR5—hepatitis B	0.000366	0.00393	CbGpPWpGaD
Hydromorphone—PTGS1—Selenium Micronutrient Network—ALB—hepatitis B	0.000354	0.00379	CbGpPWpGaD
Hydromorphone—OPRM1—G alpha (i) signalling events—CXCL10—hepatitis B	0.00035	0.00375	CbGpPWpGaD
Hydromorphone—CYP2D6—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000346	0.00371	CbGpPWpGaD
Hydromorphone—OPRD1—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.00034	0.00364	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000329	0.00353	CbGpPWpGaD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.000329	0.00353	CbGpPWpGaD
Hydromorphone—OPRK1—Peptide ligand-binding receptors—F2—hepatitis B	0.000327	0.0035	CbGpPWpGaD
Hydromorphone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000325	0.00349	CbGpPWpGaD
Hydromorphone—PTGS1—Selenium Micronutrient Network—IFNG—hepatitis B	0.000323	0.00346	CbGpPWpGaD
Hydromorphone—OPRM1—Peptide ligand-binding receptors—CCR5—hepatitis B	0.000322	0.00345	CbGpPWpGaD
Hydromorphone—OPRK1—G alpha (i) signalling events—CCR5—hepatitis B	0.000321	0.00344	CbGpPWpGaD
Hydromorphone—OPRM1—TCR Signaling Pathway—NFKB1—hepatitis B	0.000316	0.00339	CbGpPWpGaD
Hydromorphone—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.000298	0.0032	CbGpPWpGaD
Hydromorphone—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	0.000293	0.00315	CbGpPWpGaD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000291	0.00312	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—CXCL10—hepatitis B	0.000286	0.00307	CbGpPWpGaD
Hydromorphone—CYP3A4—Biological oxidations—GGT2—hepatitis B	0.000285	0.00306	CbGpPWpGaD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.000278	0.00298	CbGpPWpGaD
Hydromorphone—OPRM1—Peptide ligand-binding receptors—F2—hepatitis B	0.000276	0.00296	CbGpPWpGaD
Hydromorphone—OPRM1—G alpha (i) signalling events—CCR5—hepatitis B	0.000271	0.00291	CbGpPWpGaD
Hydromorphone—PTGS1—Selenium Micronutrient Network—NFKB1—hepatitis B	0.000269	0.00288	CbGpPWpGaD
Hydromorphone—CYP2D6—Biological oxidations—CYP2A6—hepatitis B	0.000264	0.00283	CbGpPWpGaD
Hydromorphone—OPRM1—TCR Signaling Pathway—TGFB1—hepatitis B	0.000264	0.00283	CbGpPWpGaD
Hydromorphone—CYP2C9—Biological oxidations—CYP2A6—hepatitis B	0.000262	0.00281	CbGpPWpGaD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000255	0.00274	CbGpPWpGaD
Hydromorphone—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.000252	0.0027	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—CXCL10—hepatitis B	0.000251	0.00269	CbGpPWpGaD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.00025	0.00268	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—CCR5—hepatitis B	0.000222	0.00238	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—RIT2—hepatitis B	0.00022	0.00235	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—SAG—hepatitis B	0.00022	0.00235	CbGpPWpGaD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000219	0.00235	CbGpPWpGaD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000216	0.00231	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—CXCL10—hepatitis B	0.000212	0.00227	CbGpPWpGaD
Hydromorphone—PTGS1—Selenium Micronutrient Network—TNF—hepatitis B	0.000209	0.00224	CbGpPWpGaD
Hydromorphone—CYP2D6—Biological oxidations—GGT1—hepatitis B	0.000206	0.00221	CbGpPWpGaD
Hydromorphone—CYP2C9—Biological oxidations—GGT1—hepatitis B	0.000205	0.00219	CbGpPWpGaD
Hydromorphone—OPRM1—TCR Signaling Pathway—IL6—hepatitis B	0.000199	0.00213	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—CCR5—hepatitis B	0.000194	0.00208	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—SAG—hepatitis B	0.000193	0.00206	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—RIT2—hepatitis B	0.000193	0.00206	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—F2—hepatitis B	0.00019	0.00204	CbGpPWpGaD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000185	0.00199	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000183	0.00197	CbGpPWpGaD
Hydromorphone—UGT1A9—NRF2 pathway—TGFB1—hepatitis B	0.000183	0.00196	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—AKR1B1—hepatitis B	0.00018	0.00193	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000173	0.00186	CbGpPWpGaD
Hydromorphone—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	0.000173	0.00185	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—GGT2—hepatitis B	0.000173	0.00185	CbGpPWpGaD
Hydromorphone—PTGS1—Selenium Micronutrient Network—IL6—hepatitis B	0.000169	0.00181	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—F2—hepatitis B	0.000167	0.00179	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—CCR5—hepatitis B	0.000164	0.00176	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—SAG—hepatitis B	0.000163	0.00174	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—RIT2—hepatitis B	0.000163	0.00174	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—CXCL10—hepatitis B	0.000162	0.00173	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000149	0.0016	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—CXCL10—hepatitis B	0.000147	0.00157	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—AKR1B1—hepatitis B	0.000147	0.00157	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—CXCL10—hepatitis B	0.000142	0.00152	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—F2—hepatitis B	0.000141	0.00151	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GGT2—hepatitis B	0.000141	0.00151	CbGpPWpGaD
Hydromorphone—CYP3A4—Biological oxidations—GGT1—hepatitis B	0.000135	0.00145	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—CXCL10—hepatitis B	0.000129	0.00138	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—CCR5—hepatitis B	0.000125	0.00134	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—CXCL10—hepatitis B	0.00012	0.00128	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—CCR5—hepatitis B	0.000114	0.00122	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—CCR5—hepatitis B	0.00011	0.00118	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—CXCL10—hepatitis B	0.000109	0.00117	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—F2—hepatitis B	0.000108	0.00115	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—CYP2A6—hepatitis B	0.000105	0.00112	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—CCR5—hepatitis B	9.98e-05	0.00107	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—F2—hepatitis B	9.76e-05	0.00105	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	9.75e-05	0.00105	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—GOT2—hepatitis B	9.45e-05	0.00101	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—F2—hepatitis B	9.43e-05	0.00101	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—CCR5—hepatitis B	9.29e-05	0.000996	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CXCL10—hepatitis B	8.67e-05	0.000929	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—F2—hepatitis B	8.56e-05	0.000918	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—CYP2A6—hepatitis B	8.52e-05	0.000914	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—CCR5—hepatitis B	8.43e-05	0.000904	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—GGT1—hepatitis B	8.16e-05	0.000875	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—GOT1—hepatitis B	8.16e-05	0.000875	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—F2—hepatitis B	7.97e-05	0.000854	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	7.95e-05	0.000852	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	7.85e-05	0.000842	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—AKR1B1—hepatitis B	7.78e-05	0.000834	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—AKR1B1—hepatitis B	7.71e-05	0.000827	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GOT2—hepatitis B	7.71e-05	0.000826	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CXCL10—hepatitis B	7.6e-05	0.000815	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GGT2—hepatitis B	7.46e-05	0.0008	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	7.44e-05	0.000798	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GGT2—hepatitis B	7.4e-05	0.000793	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—IL2—hepatitis B	7.24e-05	0.000776	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—F2—hepatitis B	7.24e-05	0.000776	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CCR5—hepatitis B	6.72e-05	0.000721	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GGT1—hepatitis B	6.65e-05	0.000713	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GOT1—hepatitis B	6.65e-05	0.000713	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—IL2—hepatitis B	6.57e-05	0.000705	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CXCL10—hepatitis B	6.42e-05	0.000689	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—IL2—hepatitis B	6.35e-05	0.000681	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	6.06e-05	0.00065	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CCR5—hepatitis B	5.89e-05	0.000632	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—F2—hepatitis B	5.77e-05	0.000618	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—IL2—hepatitis B	5.77e-05	0.000618	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—IL2—hepatitis B	5.37e-05	0.000575	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—AKR1B1—hepatitis B	5.09e-05	0.000545	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—F2—hepatitis B	5.06e-05	0.000542	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CCR5—hepatitis B	4.98e-05	0.000534	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GGT2—hepatitis B	4.88e-05	0.000523	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—IL2—hepatitis B	4.87e-05	0.000522	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CYP2A6—hepatitis B	4.52e-05	0.000485	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CYP2A6—hepatitis B	4.48e-05	0.00048	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—ALB—hepatitis B	4.34e-05	0.000466	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—F2—hepatitis B	4.27e-05	0.000458	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	4.18e-05	0.000448	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GOT2—hepatitis B	4.09e-05	0.000438	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GOT2—hepatitis B	4.05e-05	0.000434	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IL2—hepatitis B	3.88e-05	0.000416	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—IL6—hepatitis B	3.86e-05	0.000414	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CTNNB1—hepatitis B	3.75e-05	0.000402	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CDKN1A—hepatitis B	3.66e-05	0.000393	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PTEN—hepatitis B	3.65e-05	0.000392	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—NFKB1—hepatitis B	3.64e-05	0.00039	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—ALB—hepatitis B	3.54e-05	0.000379	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GGT1—hepatitis B	3.53e-05	0.000378	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GOT1—hepatitis B	3.53e-05	0.000378	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GOT1—hepatitis B	3.5e-05	0.000375	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GGT1—hepatitis B	3.5e-05	0.000375	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IL2—hepatitis B	3.41e-05	0.000365	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—IL6—hepatitis B	3.39e-05	0.000363	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PTEN—hepatitis B	3.31e-05	0.000355	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CTNNB1—hepatitis B	3.29e-05	0.000353	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CDKN1A—hepatitis B	3.21e-05	0.000344	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PTEN—hepatitis B	3.2e-05	0.000344	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—NFKB1—hepatitis B	3.19e-05	0.000342	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	3.19e-05	0.000342	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TGFB1—hepatitis B	3.03e-05	0.000325	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP2A6—hepatitis B	2.95e-05	0.000317	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IL2—hepatitis B	2.88e-05	0.000309	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—IL6—hepatitis B	2.86e-05	0.000307	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CTNNB1—hepatitis B	2.78e-05	0.000298	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CDKN1A—hepatitis B	2.71e-05	0.000291	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PTEN—hepatitis B	2.71e-05	0.00029	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PTEN—hepatitis B	2.7e-05	0.00029	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—NFKB1—hepatitis B	2.7e-05	0.000289	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GOT2—hepatitis B	2.67e-05	0.000287	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TGFB1—hepatitis B	2.66e-05	0.000285	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TP53—hepatitis B	2.49e-05	0.000267	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GOT1—hepatitis B	2.31e-05	0.000247	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GGT1—hepatitis B	2.31e-05	0.000247	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IL6—hepatitis B	2.28e-05	0.000245	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TGFB1—hepatitis B	2.25e-05	0.000241	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TP53—hepatitis B	2.19e-05	0.000235	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IL6—hepatitis B	2e-05	0.000215	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ALB—hepatitis B	1.88e-05	0.000201	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ALB—hepatitis B	1.86e-05	0.000199	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TP53—hepatitis B	1.85e-05	0.000198	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IL6—hepatitis B	1.69e-05	0.000181	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PTEN—hepatitis B	1.43e-05	0.000154	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PTEN—hepatitis B	1.42e-05	0.000152	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ALB—hepatitis B	1.23e-05	0.000132	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PTEN—hepatitis B	9.36e-06	0.0001	CbGpPWpGaD
